MDxHealth, Inc. Secures Coverage For Prostate Cancer Test With Two Additional Insurance Companies

Published: Dec 02, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif. and HERSTAL, Belgium, Dec. 2, 2013 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that it has signed agreements with HealthSmart, a Preferred Provider Organization (PPO) network, and Fortified Provider Network to provide their members access to the ConfirmMDx® for Prostate Cancer test. The addition of these agreements extends ConfirmMDx for Prostate Cancer testing to more than 135 million insurance covered lives throughout the U.S.

Help employers find you! Check out all the jobs and post your resume.

Back to news